The UK Court of Appeal dramatically increased Apple's patent royalty payment to Optis from $56.43 million to over $502 million for a 15-year license, a tenfold jump now heading to the Supreme Court. This escalation intensifies a high-stakes legal battle where Apple is fighting this $502 million patent bill in the UK Supreme Court in 2026. The financial implications for the tech giant are substantial, impacting future licensing strategies globally.
The High Court initially set a relatively modest annual lump sum for Apple's patent use. However, the Court of Appeal subsequently issued a tenfold higher award, creating significant uncertainty over FRAND valuation methodologies.
The UK Supreme Court's ruling is poised to either solidify or challenge the UK's ambitious stance on setting global FRAND rates for Standard Essential Patents, potentially reshaping international patent litigation.
Apple and Optis are set to face off in a UK Supreme Court appeal regarding FRAND principles, according to IAM Patent. The UK's Supreme Court will hear a case between Optis and Apple regarding the licensing of Standard Essential Patents, according to MLex. This appeal represents a critical juncture for both companies and the broader patent licensing landscape, with global implications.
The Financial Journey: From High Court to Court of Appeal
- In 2023, a High Court judge determined Apple should pay an annual lump sum of $5.13 million for 11 years, totaling $56.43 million, according to Pinsent Masons.
- The UK Court of Appeal subsequently adopted the role of fact finder, replacing the trial court's royalty with a $502 million award in the Optis v. Apple case, according to legalblogs.
The dramatic increase in the awarded royalty by the Court of Appeal demonstrates a fundamental disagreement within the UK judiciary on appropriate methodology and valuation for Standard Essential Patents.
